IBT
AKAO

International Biotechnology Trust’s Achaogen Inc AKAO Stock Holding History

International Biotechnology Trust’s Portfolio AKAO Stock Details AKAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-204,538
Closed -$2.2M – 72
2017
Q4 		$2.2M Buy
204,538
+130,000
+174% +$1.63M 0.77% 38
2017
Q3 		$1.19M Sell
74,538
-80,000
-52% -$1.52M 0.46% 43
2017
Q2 		$3.36M Sell
154,538
-125,500
-45% -$2.87M 1.28% 27
2017
Q1 		$7.07M Buy
+280,038
New +$5.75M 2.7% 10

Other funds holding AKAO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

International Biotechnology Trust's AKAO Position: Q1 2018 in Review

International Biotechnology Trust sold out of Achaogen Inc (AKAO) in Q1 2018, closing a stake of 204,538 shares — an estimated $2.2M sold.

International Biotechnology Trust first reported a position in AKAO in Q1 2017 and held it in 4 quarters. The position peaked at $7.07M in Q1 2017. 106 funds tracked by Wall St. Rank hold AKAO as of Q1 2018.

  • International Biotechnology Trust reported no remaining Achaogen Inc position as of Q1 2018 after selling out during the quarter.
  • International Biotechnology Trust sold 204,538 Achaogen Inc shares in Q1 2018, an estimated $2.2M.
  • International Biotechnology Trust first reported a position in Achaogen Inc in Q1 2017 and held it in 4 quarters.
  • International Biotechnology Trust's Achaogen Inc position peaked at $7.07M in Q1 2017.
  • 106 funds tracked by Wall St. Rank held Achaogen Inc as of Q1 2018.

Based on International Biotechnology Trust's 13F filing for Q1 2018, filed 15 May 2018.